You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The Cutting Edge Topical Targretin and Intralesional Interferon Alfa for Cutaneous Lymphoma of the Scalp
Jennifer T. Trent; Paolo Romanelli; Francisco A. Kerdel
Arch Dermatol 2002; 138: 1421-1423.
[Extract][Full text][PDF]
Observations Circulating CD4+CD7- Lymphocyte Burden and Rapidity of Response: Predictors of Outcome in the Treatment of Sézary Syndrome and Erythrodermic Mycosis Fungoides With Extracorporeal Photopheresis
Seth R. Stevens; Elma D. Baron; Susan Masten; Kevin D. Cooper
Arch Dermatol 2002; 138: 1347-1350.
[Abstract][Full text][PDF]
Observations Long-term Remission After Allogeneic Hematopoietic Stem Cell Transplantation for Refractory Cutaneous T-Cell Lymphoma
Joan Guitart; Scott C. Wickless; Yu Oyama; Timothy M. Kuzel; Steve T. Rosen; Ann Traynor; Richard Burt
Arch Dermatol 2002; 138: 1359-1365.
[Abstract][Full text][PDF]
The Cutting Edge Treatment of Stage IA Cutaneous T-Cell Lymphoma With Topical Application of the Immune Response Modifier Imiquimod
Karen Rebecca Suchin; Jacqueline M. Junkins-Hopkins; Alain H. Rook; Hospital of the University of Pennsylvania, Philadelphia
Arch Dermatol 2002; 138: 1137-1139.
[Extract][Full text][PDF]
Studies Treatment of Cutaneous T-Cell Lymphoma With Combined Immunomodulatory Therapy: A 14-Year Experience at a Single Institution
Karen Rebecca Suchin; Andrew J. Cucchiara; Scott L. Gottleib; Jonathan T. Wolfe; Barbara J. DeNardo; William H. Macey; Patricia G. Bromley; Carmela C. Vittorio; Alain H. Rook
Arch Dermatol 2002; 138: 1054-1060.
[Abstract][Full text][PDF]
The Cutting Edge Denileukin Diftitox for the Treatment of Panniculitic Lymphoma
Karen S. McGinnis; Michael Shapiro; Jacqueline M. Junkins-Hopkins; Mitchell Smith; Stuart R. Lessin; Carmela C. Vittorio; Alain H. Rook
Arch Dermatol 2002; 138: 740-742.
[Extract][Full text][PDF]
The Art and the Calling Healing From the Inside Out: One Person's Path With Cutaneous T-Cell Lymphoma–Mycosis Fungoides
Studies Phase 1 and 2 Trial of Bexarotene Gel for Skin-Directed Treatment of Patients With Cutaneous T-Cell Lymphoma
Debra Breneman; Madeleine Duvic; Timothy Kuzel; Richard Yocum; Joseph Truglia; Victor J. Stevens
Arch Dermatol 2002; 138: 325-332.
[Abstract][Full text][PDF]
Editorials Bexarotene Gel: A Food and Drug Administration–Approved Skin-Directed Therapy for Early-Stage Cutaneous T-Cell Lymphoma
